25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Theratechnologies Inc.
Buy, Hold or Sell?

Let's analyze Theratech together

I guess you are interested in Theratechnologies Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Theratechnologies Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Theratechnologies Inc.

I send you an email if I find something interesting about Theratechnologies Inc..

1. Quick Overview

1.1. Quick analysis of Theratech (30 sec.)










1.2. What can you expect buying and holding a share of Theratech? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.40
Expected worth in 1 year
$0.11
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$0.51
Return On Investment
39.7%

For what price can you sell your share?

Current Price per Share
$1.28
Expected price per share
$1.36 - $1.67
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Theratech (5 min.)




Live pricePrice per Share (EOD)
$1.28
Intrinsic Value Per Share
$1.05 - $5.35
Total Value Per Share
$0.66 - $4.95

2.2. Growth of Theratech (5 min.)




Is Theratech growing?

Current yearPrevious yearGrowGrow %
How rich?-$19.6m-$28.6m$2.2m8.7%

How much money is Theratech making?

Current yearPrevious yearGrowGrow %
Making money$144.2k-$6.6m$6.8m4,721.7%
Net Profit Margin0.7%-32.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Theratech (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Theratech?

Welcome investor! Theratech's management wants to use your money to grow the business. In return you get a share of Theratech.

First you should know what it really means to hold a share of Theratech. And how you can make/lose money.

Speculation

The Price per Share of Theratech is $1.28. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Theratech.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Theratech, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.40. Based on the TTM, the Book Value Change Per Share is $0.13 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Theratech.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.064.9%0.000.1%-0.19-15.1%-0.14-11.0%-0.09-6.7%
Usd Book Value Change Per Share0.075.6%0.139.9%-0.16-12.8%-0.05-4.2%-0.02-1.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.075.6%0.139.9%-0.16-12.8%-0.05-4.2%-0.02-1.9%
Usd Price Per Share1.25-1.31-1.55-2.33-3.05-
Price to Earnings Ratio4.99-0.43--2.14--4.17-1.58-
Price-to-Total Gains Ratio17.48--22.96--11.58--23.07-68.38-
Price to Book Ratio-3.14--2.69--3.06-3.57-4.47-
Price-to-Total Gains Ratio17.48--22.96--11.58--23.07-68.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.28
Number of shares781
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.13-0.05
Usd Total Gains Per Share0.13-0.05
Gains per Quarter (781 shares)99.28-42.19
Gains per Year (781 shares)397.11-168.78
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103973870-169-179
207947840-338-348
30119111810-506-517
40158815780-675-686
50198619750-844-855
60238323720-1013-1024
70278027690-1181-1193
80317731660-1350-1362
90357435630-1519-1531
100397139600-1688-1700

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%2.010.00.016.7%2.018.00.010.0%8.032.00.020.0%17.093.00.015.5%
Book Value Change Per Share2.01.01.050.0%2.09.01.016.7%3.016.01.015.0%13.026.01.032.5%41.068.01.037.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.0110.00.0%
Total Gains per Share2.01.01.050.0%2.09.01.016.7%3.016.01.015.0%13.026.01.032.5%41.068.01.037.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Theratechnologies Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0710.127-44%-0.163+329%-0.054+176%-0.024+134%
Book Value Per Share---0.399-0.557+40%-0.623+56%0.005-8734%0.323-224%
Current Ratio--1.0820.985+10%0.735+47%1.590-32%1.752-38%
Debt To Asset Ratio--1.2821.404-9%1.393-8%1.068+20%0.740+73%
Debt To Equity Ratio----0%-0%12.624-100%7.148-100%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0630.002+3779%-0.193+408%-0.141+325%-0.086+238%
Free Cash Flow Per Share--0.0930.012+688%-0.045+149%-0.045+148%-0.023+124%
Free Cash Flow To Equity Per Share--0.0550.083-33%-0.025+145%-0.003+106%0.030+84%
Gross Profit Margin---1.0401.744-160%3.942-126%2.497-142%1.760-159%
Intrinsic Value_10Y_max--5.346--------
Intrinsic Value_10Y_min--1.055--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min---0.133--------
Intrinsic Value_3Y_max--0.408--------
Intrinsic Value_3Y_min---0.194--------
Intrinsic Value_5Y_max--1.309--------
Intrinsic Value_5Y_min---0.032--------
Market Cap58854400.000-5%61715875.00062522464.188-1%71154050.000-13%107407212.838-43%140525341.419-56%
Net Profit Margin--0.1370.007+1829%-0.323+336%-0.331+342%-27.722+20369%
Operating Margin--0.2750.140+96%-0.193+170%-0.232+184%-24.392+8973%
Operating Ratio--0.7250.853-15%1.200-40%-0.037+105%-12.298+1796%
Pb Ratio-3.212-2%-3.136-2.690-14%-3.059-2%3.571-188%4.468-170%
Pe Ratio5.111+2%4.9920.435+1048%-2.140+143%-4.165+183%1.582+216%
Price Per Share1.280+2%1.2501.310-5%1.548-19%2.326-46%3.051-59%
Price To Free Cash Flow Ratio3.432+2%3.351-1.744+152%-4.421+232%-2.222+166%-12.672+478%
Price To Total Gains Ratio17.904+2%17.484-22.955+231%-11.581+166%-23.068+232%68.383-74%
Quick Ratio--1.0080.934+8%0.593+70%1.309-23%1.415-29%
Return On Assets--0.0440.002+1707%-0.077+274%-0.058+230%-0.043+197%
Return On Equity----0%-0%-1.1410%-0.6290%
Total Gains Per Share--0.0710.127-44%-0.163+329%-0.054+176%-0.024+134%
Usd Book Value---19677000.000-26363998.750+34%-28661500.000+46%65000.250-30372%14760633.600-233%
Usd Book Value Change Per Share--0.0710.127-44%-0.163+329%-0.054+176%-0.024+134%
Usd Book Value Per Share---0.399-0.557+40%-0.623+56%0.005-8734%0.323-224%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0630.002+3779%-0.193+408%-0.141+325%-0.086+238%
Usd Free Cash Flow--4603998.000589713.000+681%-2080750.000+145%-2056707.400+145%-1039139.944+123%
Usd Free Cash Flow Per Share--0.0930.012+688%-0.045+149%-0.045+148%-0.023+124%
Usd Free Cash Flow To Equity Per Share--0.0550.083-33%-0.025+145%-0.003+106%0.030+84%
Usd Market Cap58854400.000-5%61715875.00062522464.188-1%71154050.000-13%107407212.838-43%140525341.419-56%
Usd Price Per Share1.280+2%1.2501.310-5%1.548-19%2.326-46%3.051-59%
Usd Profit--3091000.000144250.000+2043%-6666750.000+316%-6016750.000+295%-3729522.975+221%
Usd Revenue--22600000.00022229337.000+2%20748750.000+9%18906217.350+20%13510131.457+67%
Usd Total Gains Per Share--0.0710.127-44%-0.163+329%-0.054+176%-0.024+134%
 EOD+3 -5MRQTTM+20 -12YOY+26 -65Y+20 -1310Y+19 -14

3.3 Fundamental Score

Let's check the fundamental score of Theratechnologies Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-155.111
Price to Book Ratio (EOD)Between0-1-3.212
Net Profit Margin (MRQ)Greater than00.137
Operating Margin (MRQ)Greater than00.275
Quick Ratio (MRQ)Greater than11.008
Current Ratio (MRQ)Greater than11.082
Debt to Asset Ratio (MRQ)Less than11.282
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.044
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Theratechnologies Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.042
Ma 20Greater thanMa 501.267
Ma 50Greater thanMa 1001.251
Ma 100Greater thanMa 2001.326
OpenGreater thanClose1.470
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Theratechnologies Inc.

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its pipeline products include F8 Formulation that is in Phase 2b/3 clinical trials for studying tesamorelin for the treatment of nonalcoholic steatohepatitis; multi -dose pen injector for the administration of tesamorelin; SORT1+ Technology Platform for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; Sudocetaxel Zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Fundamental data was last updated by Penke on 2024-10-26 01:03:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Theratech earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Theratech to the Biotechnology industry mean.
  • A Net Profit Margin of 13.7% means that $0.14 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Theratechnologies Inc.:

  • The MRQ is 13.7%. The company is making a huge profit. +2
  • The TTM is 0.7%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ13.7%TTM0.7%+13.0%
TTM0.7%YOY-32.3%+33.0%
TTM0.7%5Y-33.1%+33.9%
5Y-33.1%10Y-2,772.2%+2,739.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.7%-135.5%+149.2%
TTM0.7%-205.3%+206.0%
YOY-32.3%-207.5%+175.2%
5Y-33.1%-353.2%+320.1%
10Y-2,772.2%-464.5%-2,307.7%
4.3.1.2. Return on Assets

Shows how efficient Theratech is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Theratech to the Biotechnology industry mean.
  • 4.4% Return on Assets means that Theratech generated $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Theratechnologies Inc.:

  • The MRQ is 4.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.2%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.4%TTM0.2%+4.2%
TTM0.2%YOY-7.7%+8.0%
TTM0.2%5Y-5.8%+6.0%
5Y-5.8%10Y-4.3%-1.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4%-10.7%+15.1%
TTM0.2%-11.8%+12.0%
YOY-7.7%-11.0%+3.3%
5Y-5.8%-12.7%+6.9%
10Y-4.3%-14.3%+10.0%
4.3.1.3. Return on Equity

Shows how efficient Theratech is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Theratech to the Biotechnology industry mean.
  • 0.0% Return on Equity means Theratech generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Theratechnologies Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-114.1%+114.1%
5Y-114.1%10Y-62.9%-51.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.5%+13.5%
TTM--15.9%+15.9%
YOY--13.5%+13.5%
5Y-114.1%-18.5%-95.6%
10Y-62.9%-19.0%-43.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Theratechnologies Inc..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Theratech is operating .

  • Measures how much profit Theratech makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Theratech to the Biotechnology industry mean.
  • An Operating Margin of 27.5% means the company generated $0.27  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Theratechnologies Inc.:

  • The MRQ is 27.5%. The company is operating very efficient. +2
  • The TTM is 14.0%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ27.5%TTM14.0%+13.4%
TTM14.0%YOY-19.3%+33.3%
TTM14.0%5Y-23.2%+37.2%
5Y-23.2%10Y-2,439.2%+2,416.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ27.5%-282.6%+310.1%
TTM14.0%-313.4%+327.4%
YOY-19.3%-223.5%+204.2%
5Y-23.2%-384.9%+361.7%
10Y-2,439.2%-494.6%-1,944.6%
4.3.2.2. Operating Ratio

Measures how efficient Theratech is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.73 means that the operating costs are $0.73 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Theratechnologies Inc.:

  • The MRQ is 0.725. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.853. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.725TTM0.853-0.128
TTM0.853YOY1.200-0.347
TTM0.8535Y-0.037+0.890
5Y-0.03710Y-12.298+12.261
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7252.835-2.110
TTM0.8533.157-2.304
YOY1.2003.301-2.101
5Y-0.0374.794-4.831
10Y-12.2986.520-18.818
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Theratechnologies Inc..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Theratech is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.08 means the company has $1.08 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Theratechnologies Inc.:

  • The MRQ is 1.082. The company is just able to pay all its short-term debts.
  • The TTM is 0.985. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ1.082TTM0.985+0.098
TTM0.985YOY0.735+0.250
TTM0.9855Y1.590-0.606
5Y1.59010Y1.752-0.162
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0823.747-2.665
TTM0.9853.919-2.934
YOY0.7354.719-3.984
5Y1.5905.960-4.370
10Y1.7526.285-4.533
4.4.3.2. Quick Ratio

Measures if Theratech is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Theratech to the Biotechnology industry mean.
  • A Quick Ratio of 1.01 means the company can pay off $1.01 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Theratechnologies Inc.:

  • The MRQ is 1.008. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 0.934. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.008TTM0.934+0.074
TTM0.934YOY0.593+0.341
TTM0.9345Y1.309-0.375
5Y1.30910Y1.415-0.106
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0083.349-2.341
TTM0.9343.522-2.588
YOY0.5934.691-4.098
5Y1.3095.927-4.618
10Y1.4156.469-5.054
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Theratechnologies Inc..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Theratech assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Theratech to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.28 means that Theratech assets are financed with 128.2% credit (debt) and the remaining percentage (100% - 128.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Theratechnologies Inc.:

  • The MRQ is 1.282. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.404. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.282TTM1.404-0.122
TTM1.404YOY1.393+0.011
TTM1.4045Y1.068+0.336
5Y1.06810Y0.740+0.328
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2820.338+0.944
TTM1.4040.347+1.057
YOY1.3930.307+1.086
5Y1.0680.365+0.703
10Y0.7400.380+0.360
4.5.4.2. Debt to Equity Ratio

Measures if Theratech is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Theratech to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Theratechnologies Inc.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y12.624-12.624
5Y12.62410Y7.148+5.476
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.392-0.392
TTM-0.439-0.439
YOY-0.375-0.375
5Y12.6240.450+12.174
10Y7.1480.488+6.660
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Theratech generates.

  • Above 15 is considered overpriced but always compare Theratech to the Biotechnology industry mean.
  • A PE ratio of 4.99 means the investor is paying $4.99 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Theratechnologies Inc.:

  • The EOD is 5.111. Based on the earnings, the company is cheap. +2
  • The MRQ is 4.992. Based on the earnings, the company is cheap. +2
  • The TTM is 0.435. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD5.111MRQ4.992+0.120
MRQ4.992TTM0.435+4.557
TTM0.435YOY-2.140+2.574
TTM0.4355Y-4.165+4.600
5Y-4.16510Y1.582-5.747
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.111-2.368+7.479
MRQ4.992-2.494+7.486
TTM0.435-2.994+3.429
YOY-2.140-3.442+1.302
5Y-4.165-5.973+1.808
10Y1.582-6.275+7.857
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Theratechnologies Inc.:

  • The EOD is 3.432. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 3.351. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -1.744. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD3.432MRQ3.351+0.080
MRQ3.351TTM-1.744+5.095
TTM-1.744YOY-4.421+2.677
TTM-1.7445Y-2.222+0.479
5Y-2.22210Y-12.672+10.450
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.432-3.220+6.652
MRQ3.351-3.261+6.612
TTM-1.744-3.558+1.814
YOY-4.421-4.567+0.146
5Y-2.222-8.099+5.877
10Y-12.672-8.939-3.733
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Theratech is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -3.14 means the investor is paying $-3.14 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Theratechnologies Inc.:

  • The EOD is -3.212. Based on the equity, the company is expensive. -2
  • The MRQ is -3.136. Based on the equity, the company is expensive. -2
  • The TTM is -2.690. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.212MRQ-3.136-0.075
MRQ-3.136TTM-2.690-0.446
TTM-2.690YOY-3.059+0.369
TTM-2.6905Y3.571-6.261
5Y3.57110Y4.468-0.897
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.2121.952-5.164
MRQ-3.1361.984-5.120
TTM-2.6902.195-4.885
YOY-3.0592.392-5.451
5Y3.5713.593-0.022
10Y4.4684.220+0.248
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Theratechnologies Inc..

4.8.1. Institutions holding Theratechnologies Inc.

Institutions are holding 51.265% of the shares of Theratechnologies Inc..

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30Nantahala Capital Management, LLC11.66690.220253644562682228100
2024-06-30Soleus Capital Management, L.P.10.44230.5928480137600
2024-06-30AIGH Capital Management, LLC8.10181.6303372520400
2024-06-30Morgan Stanley - Brokerage Accounts4.89830.00022252233-2252231-50
2024-06-30Advisor Group Holdings, Inc.0.31510.000514487900
2024-06-30Cyndeo Wealth Partners LLC0.22640.01141041201041200
2024-06-30Federation des caisses Desjardins du Quebec0.20230.0007930123869871.2487
2024-06-30Stifel Financial Corp0.17580.000180846887512.3314
2024-06-30Sontag Advisory LLC0.11150.00095125000
2024-06-30Hamilton Capital Management Inc0.09590.00474407200
2024-06-30Summit Trail Advisors, LLC0.0720.00123309000
2024-06-30Creative Financial Designs Inc0.06160.0035283437502.7181
2024-06-30Bare Financial Services Inc0.05990.02072755700
2024-06-30Beacon Pointe Advisors, LLC0.05770.00042652500
2024-06-30Geode Capital Management, LLC0.055902568100
2024-06-30Bank of Montreal0.039701826200
2024-06-30BMO Capital Markets Corp.0.039701826200
2024-06-30UBS Group AG0.0381017538-1756-9.1013
2024-09-30Kohmann Bosshard Financial Services, LLC0.03350.00241540200
2024-06-30Greatmark Investment Partners Inc0.03240.0031487500
Total 36.72682.49316886983+580684+3.4%

4.9.2. Funds holding Theratechnologies Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-08-31Fidelity Nasdaq Composite Index0.05590.00022568100
Total 0.05590.00022568100.0%
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-05-312023-08-312023-11-302024-02-292024-05-31
Net Income from Continuing Operations  -10,0139,267-746-2,009-2,755-1,726-4,4815,468987



5.2. Latest Balance Sheet

Balance Sheet of 2024-05-31. Currency in USD. All numbers in thousands.

Summary
Total Assets69,712
Total Liabilities89,389
Total Stockholder Equity-19,677
 As reported
Total Liabilities 89,389
Total Stockholder Equity+ -19,677
Total Assets = 69,712

Assets

Total Assets69,712
Total Current Assets57,249
Long-term Assets12,463
Total Current Assets
Cash And Cash Equivalents 34,690
Short-term Investments 4,169
Net Receivables 10,315
Inventory 5,989
Other Current Assets 483
Total Current Assets  (as reported)57,249
Total Current Assets  (calculated)55,646
+/- 1,603
Long-term Assets
Property Plant Equipment 788
Intangible Assets 11,416
Long-term Assets Other 259
Long-term Assets  (as reported)12,463
Long-term Assets  (calculated)12,463
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities52,896
Long-term Liabilities36,493
Total Stockholder Equity-19,677
Total Current Liabilities
Short-term Debt 20,902
Short Long Term Debt 17,455
Accounts payable 23,758
Other Current Liabilities 8,198
Total Current Liabilities  (as reported)52,896
Total Current Liabilities  (calculated)70,313
+/- 17,417
Long-term Liabilities
Long term Debt 41,080
Capital Lease Obligations 785
Long-term Liabilities Other 15
Long-term Liabilities  (as reported)36,493
Long-term Liabilities  (calculated)41,880
+/- 5,387
Total Stockholder Equity
Common Stock363,927
Retained Earnings -409,062
Accumulated Other Comprehensive Income 860
Other Stockholders Equity 0
Total Stockholder Equity (as reported)-19,677
Total Stockholder Equity (calculated)-44,275
+/- 24,598
Other
Capital Stock363,927
Cash and Short Term Investments 38,859
Common Stock Shares Outstanding 49,373
Current Deferred Revenue38
Liabilities and Stockholders Equity 69,712
Net Debt 22,455
Net Invested Capital 35,327
Net Working Capital 5,344
Property Plant and Equipment Gross 917
Short Long Term Debt Total 57,145



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-05-312024-02-292023-11-302023-08-312023-05-312023-02-282022-11-302022-08-312022-05-312022-02-282021-11-302021-08-312021-05-312021-02-282020-11-302020-08-312020-05-312020-02-292019-11-302019-08-312019-05-312019-02-282018-11-302018-08-312018-05-312018-02-282017-11-302017-08-312017-05-312017-02-282016-11-302016-08-312016-05-312016-02-292015-11-302015-08-312015-05-312015-02-282014-11-302014-08-312014-05-312014-02-282013-11-302013-08-312013-05-312013-02-282012-11-302012-08-312012-05-312012-02-292011-11-302011-08-312011-05-312011-02-282010-11-302010-08-312010-05-312010-02-282009-11-302009-08-312009-05-312009-02-282008-11-302008-08-312008-05-312008-02-292007-11-302007-08-312007-05-312007-02-282006-11-302006-08-312006-05-312006-02-282005-11-302005-08-312005-05-312005-02-282004-11-302004-08-312004-05-312004-02-292003-11-302003-08-312003-05-312003-02-282002-11-302002-08-312002-05-312002-02-282001-11-302001-08-312001-05-312001-02-282000-11-302000-08-312000-05-312000-02-291999-11-301999-08-311999-05-311999-02-281998-11-301998-08-311998-05-311998-02-281997-11-301997-08-311997-05-311997-02-28
> Total Assets 
11,399
10,086
9,719
8,503
7,518
13,868
12,782
12,435
11,734
15,124
18,869
18,336
20,192
41,045
47,972
54,992
52,977
53,266
93,270
90,376
102,568
99,192
95,019
89,781
88,915
89,059
83,369
72,875
77,593
69,845
58,540
57,227
63,114
50,861
49,040
45,931
43,203
57,126
51,396
44,650
84,561
85,365
80,143
74,553
94,425
84,276
68,156
43,115
61,968
65,036
68,107
65,381
58,880
54,835
47,868
70,279
66,438
62,965
57,802
51,204
46,006
41,601
41,406
36,574
32,455
28,700
25,710
23,457
19,121
34,281
30,242
28,617
29,064
30,517
39,126
37,576
37,631
39,770
38,621
39,445
52,085
56,149
58,214
59,138
56,396
54,081
107,759
111,116
116,490
110,635
108,070
117,555
110,667
111,754
101,504
100,142
135,080
133,523
127,002
119,212
108,670
95,359
95,855
93,260
79,240
56,686
56,686
77,769
70,205
69,712
69,71270,20577,76956,68656,68679,24093,26095,85595,359108,670119,212127,002133,523135,080100,142101,504111,754110,667117,555108,070110,635116,490111,116107,75954,08156,39659,13858,21456,14952,08539,44538,62139,77037,63137,57639,12630,51729,06428,61730,24234,28119,12123,45725,71028,70032,45536,57441,40641,60146,00651,20457,80262,96566,43870,27947,86854,83558,88065,38168,10765,03661,96843,11568,15684,27694,42574,55380,14385,36584,56144,65051,39657,12643,20345,93149,04050,86163,11457,22758,54069,84577,59372,87583,36989,05988,91589,78195,01999,192102,56890,37693,27053,26652,97754,99247,97241,04520,19218,33618,86915,12411,73412,43512,78213,8687,5188,5039,71910,08611,399
   > Total Current Assets 
10,960
9,578
9,359
7,730
6,745
12,907
11,896
11,523
10,739
14,107
16,928
16,434
18,194
31,635
22,453
20,983
14,976
19,351
41,584
35,339
41,222
33,603
28,480
28,483
38,065
42,717
36,608
32,760
39,791
28,604
14,603
17,553
20,059
19,193
18,298
14,720
14,345
19,939
20,544
18,817
60,219
35,856
36,496
34,420
46,945
38,753
27,578
11,418
17,683
20,710
26,496
15,239
14,219
15,540
9,673
33,888
18,670
19,207
18,267
17,846
20,218
18,726
19,556
17,202
15,317
16,067
14,007
12,331
10,080
14,597
12,930
15,296
16,206
18,093
27,111
25,823
22,972
20,138
19,670
21,163
33,522
30,436
31,817
34,567
33,315
32,416
68,004
73,606
72,486
69,156
68,810
76,181
68,795
72,163
63,994
64,807
101,859
102,439
97,767
91,908
83,490
78,302
77,872
73,370
60,936
40,565
40,565
63,297
57,320
57,249
57,24957,32063,29740,56540,56560,93673,37077,87278,30283,49091,90897,767102,439101,85964,80763,99472,16368,79576,18168,81069,15672,48673,60668,00432,41633,31534,56731,81730,43633,52221,16319,67020,13822,97225,82327,11118,09316,20615,29612,93014,59710,08012,33114,00716,06715,31717,20219,55618,72620,21817,84618,26719,20718,67033,8889,67315,54014,21915,23926,49620,71017,68311,41827,57838,75346,94534,42036,49635,85660,21918,81720,54419,93914,34514,72018,29819,19320,05917,55314,60328,60439,79132,76036,60842,71738,06528,48328,48033,60341,22235,33941,58419,35114,97620,98322,45331,63518,19416,43416,92814,10710,73911,52311,89612,9076,7457,7309,3599,57810,960
       Cash And Cash Equivalents 
9,645
7,981
8,351
6,957
5,691
11,328
10,251
10,352
9,347
13,157
15,991
272
1,930
12,147
11,757
883
1,174
7,125
20,517
1,552
13,062
7,105
9,568
125
3,332
4,357
1,901
41
15,942
2,634
346
367
4,500
6,056
4,015
931
62
1,549
1,399
14
47,005
11,825
6,193
2,577
17,741
8,028
9,051
107
5,428
3,517
11,618
1,436
3,170
3,314
2,235
26,139
544
1,034
516
2,478
63
1,011
2,562
1,522
77
390
1,539
913
214
285
2,324
608
3,169
3,657
11,448
11,517
8,363
3,612
244
789
5,467
3,015
1,031
1,364
1,355
2,335
34,241
38,997
40,194
30,089
31,034
28,661
23,600
21,440
17,242
12,737
49,116
38,235
32,446
20,399
14,342
13,200
23,416
23,856
20,023
14,966
14,966
34,097
31,162
34,690
34,69031,16234,09714,96614,96620,02323,85623,41613,20014,34220,39932,44638,23549,11612,73717,24221,44023,60028,66131,03430,08940,19438,99734,2412,3351,3551,3641,0313,0155,4677892443,6128,36311,51711,4483,6573,1696082,3242852149131,539390771,5222,5621,011632,4785161,03454426,1392,2353,3143,1701,43611,6183,5175,4281079,0518,02817,7412,5776,19311,82547,005141,3991,549629314,0156,0564,5003673462,63415,942411,9014,3573,3321259,5687,10513,0621,55220,5177,1251,17488311,75712,1471,93027215,99113,1579,34710,35210,25111,3285,6916,9578,3517,9819,645
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
14,872
14,403
17,553
9,174
17,861
11,463
9,987
18,715
31,254
24,038
22,478
14,686
24,984
30,226
33,623
31,055
30,280
21,031
22,576
11,694
14,749
12,922
9,305
9,931
10,715
10,725
14,150
14,888
15,789
9,093
18,632
25,321
27,452
24,977
26,477
15,891
8,821
7,708
11,721
8,730
9,489
5,959
5,016
1,598
1,824
10,558
6,737
1,185
728
3,611
156
828
150
111
110
69
93
49
37
32
2,177
0
0
0
0
16
21
3,202
4,947
13,287
10,900
13,588
16,513
17,486
10,725
10,732
9,691
9,826
10,122
10,933
11,964
10,979
10,203
9,605
8,223
7,600
18,479
19,138
22,979
19,941
19,291
13,046
9,214
9,133
7,908
7,908
6,290
4,861
4,169
4,1694,8616,2907,9087,9089,1339,21413,04619,29119,94122,97919,13818,4797,6008,2239,60510,20310,97911,96410,93310,1229,8269,69110,73210,72517,48616,51313,58810,90013,2874,9473,202211600002,17732374993691101111508281563,6117281,1856,73710,5581,8241,5985,0165,9599,4898,73011,7217,7088,82115,89126,47724,97727,45225,32118,6329,09315,78914,88814,15010,72510,7159,9319,30512,92214,74911,69422,57621,03130,28031,05533,62330,22624,98414,68622,47824,03831,25418,7159,98711,46317,8619,17417,55314,40314,87200000000000
       Net Receivables 
877
1,161
720
703
984
1,373
1,455
781
1,061
610
468
1,019
1,585
1,535
1,131
1,544
1,576
1,169
1,256
1,376
2,755
2,484
2,190
1,753
1,653
1,776
773
1,217
1,485
1,938
1,218
968
1,152
1,268
1,533
1,058
1,331
1,487
1,699
1,927
1,830
2,235
1,808
1,868
2,287
2,945
1,919
1,928
2,372
2,890
3,092
1,615
2,012
2,064
608
484
1,920
2,347
3,255
2,063
769
1,660
412
1,600
1,265
2,094
694
461
263
3,979
70
2,059
2,029
3,341
4,564
3,441
4,340
5,570
5,304
4,994
4,587
5,935
6,788
7,553
5,090
7,826
11,637
10,952
7,986
13,421
11,374
10,116
9,886
12,191
8,475
13,185
11,236
10,827
13,513
10,964
13,948
12,853
11,530
12,344
10,383
9,115
9,115
13,551
13,561
10,315
10,31513,56113,5519,1159,11510,38312,34411,53012,85313,94810,96413,51310,82711,23613,1858,47512,1919,88610,11611,37413,4217,98610,95211,6377,8265,0907,5536,7885,9354,5874,9945,3045,5704,3403,4414,5643,3412,0292,059703,9792634616942,0941,2651,6004121,6607692,0633,2552,3471,9204846082,0642,0121,6153,0922,8902,3721,9281,9192,9452,2871,8681,8082,2351,8301,9271,6991,4871,3311,0581,5331,2681,1529681,2181,9381,4851,2177731,7761,6531,7532,1902,4842,7551,3761,2561,1691,5761,5441,1311,5351,5851,0194686101,0617811,4551,3739847037201,161877
       Inventory 
219
218
144
70
70
69
127
260
199
136
67
68
69
200
194
491
569
836
876
730
967
1,156
1,475
1,274
2,374
2,397
2,264
763
681
664
1,057
1,299
1,255
2,088
2,230
1,652
1,787
2,174
2,048
745
1,858
2,446
2,265
2,109
1,184
596
240
242
1,256
1,462
1,455
2,104
2,142
4,261
4,324
4,234
4,718
8,004
10,827
10,006
13,651
13,789
14,019
12,874
12,973
12,338
10,763
10,381
9,026
9,333
9,652
9,305
9,412
9,903
9,641
9,532
8,929
9,640
9,624
9,133
8,666
8,826
8,282
7,239
7,369
8,575
8,581
11,084
11,502
12,861
12,860
20,929
20,670
24,735
25,669
25,145
27,344
28,578
27,293
29,141
26,134
24,976
23,141
19,688
15,110
6,723
6,723
6,066
5,533
5,989
5,9895,5336,0666,7236,72315,11019,68823,14124,97626,13429,14127,29328,57827,34425,14525,66924,73520,67020,92912,86012,86111,50211,0848,5818,5757,3697,2398,2828,8268,6669,1339,6249,6408,9299,5329,6419,9039,4129,3059,6529,3339,02610,38110,76312,33812,97312,87414,01913,78913,65110,00610,8278,0044,7184,2344,3244,2612,1422,1041,4551,4621,2562422405961,1842,1092,2652,4461,8587452,0482,1741,7871,6522,2302,0881,2551,2991,0576646817632,2642,3972,3741,2741,4751,156967730876836569491194200696867136199260127697070144218219
       Other Current Assets 
219
218
144
0
0
137
63
130
133
203
401
204
207
200
196
205
195
233
221
427
399
380
561
347
-1
563
615
460
652
791
288
170
232
476
588
364
442
579
509
343
432
718
909
414
757
707
476
320
560
639
940
596
257
257
267
1,207
929
1,084
2,484
2,571
2,123
6
1,735
1,604
1,428
1,982
996
523
528
4,806
852
1,198
246
1,211
1,464
1,414
1,318
1,317
1,306
1,325
1,545
1,775
2,055
1,997
2,030
3,008
2,895
3,114
2,978
2,663
2,609
5,089
3,660
3,594
3,202
7,755
6,563
6,320
5,377
11,523
9,125
7,982
6,739
8,268
6,287
1,853
1,853
3,293
2,202
483
4832,2023,2931,8531,8536,2878,2686,7397,9829,12511,5235,3776,3206,5637,7553,2023,5943,6605,0892,6092,6632,9783,1142,8953,0082,0301,9972,0551,7751,5451,3251,3061,3171,3181,4141,4641,2112461,1988524,8065285239961,9821,4281,6041,73562,1232,5712,4841,0849291,207267257257596940639560320476707757414909718432343509579442364588476232170288791652460615563-13475613803994272212331952051962002072044012031331306313700144218219
   > Long-term Assets 
438
508
360
773
773
961
886
911
994
1,017
1,940
1,901
1,999
9,410
25,519
34,010
38,001
33,916
51,686
55,037
61,346
65,590
66,539
61,298
50,850
46,342
46,762
40,115
37,803
41,241
43,937
39,674
43,054
31,668
30,742
31,211
28,858
37,187
30,852
25,833
24,342
49,509
43,647
40,133
47,480
45,523
40,578
31,697
44,286
44,326
41,611
50,143
44,661
39,295
38,195
36,391
47,768
43,758
39,535
33,358
25,789
22,875
21,850
19,372
17,138
12,634
11,703
11,126
8,662
19,684
17,312
13,321
12,858
12,424
12,015
11,753
14,659
19,632
18,952
18,282
18,562
25,714
26,397
24,572
23,082
21,664
21,488
37,510
28,137
26,833
25,835
41,374
41,872
29,828
28,967
35,335
33,221
31,084
28,894
26,683
24,531
16,410
17,983
19,890
18,304
16,121
16,121
14,472
12,885
12,463
12,46312,88514,47216,12116,12118,30419,89017,98316,41024,53126,68328,89431,08433,22135,33528,96729,82841,87241,37425,83526,83328,13737,51021,48821,66423,08224,57226,39725,71418,56218,28218,95219,63214,65911,75312,01512,42412,85813,32117,31219,6848,66211,12611,70312,63417,13819,37221,85022,87525,78933,35839,53543,75847,76836,39138,19539,29544,66150,14341,61144,32644,28631,69740,57845,52347,48040,13343,64749,50924,34225,83330,85237,18728,85831,21130,74231,66843,05439,67443,93741,24137,80340,11546,76246,34250,85061,29866,53965,59061,34655,03751,68633,91638,00134,01025,5199,4101,9991,9011,9401,017994911886961773773360508438
       Property Plant Equipment 
365
363
288
281
351
481
380
391
398
407
468
407
551
801
681
957
1,246
1,274
1,329
1,737
2,454
4,144
4,547
4,824
5,073
5,064
4,726
4,102
3,801
3,509
1,514
7,032
1,753
1,817
1,869
6,679
1,722
1,675
1,538
1,384
1,408
1,539
1,629
1,721
1,689
1,542
1,321
1,046
982
1,111
1,030
1,162
1,150
1,100
1,043
1,040
1,035
989
1,035
938
838
752
717
405
350
324
293
265
241
233
220
128
86
83
81
83
89
95
99
35
62
58
53
48
44
59
54
101
841
1,180
1,130
1,071
3,858
3,707
3,642
3,483
3,346
3,224
3,050
2,854
2,718
2,919
3,175
3,089
2,230
2,192
2,192
1,976
917
788
7889171,9762,1922,1922,2303,0893,1752,9192,7182,8543,0503,2243,3463,4833,6423,7073,8581,0711,1301,1808411015459444853586235999589838183861282202332412652933243504057177528389381,0359891,0351,0401,0431,1001,1501,1621,0301,1119821,0461,3211,5421,6891,7211,6291,5391,4081,3841,5381,6751,7226,6791,8691,8171,7537,0321,5143,5093,8014,1024,7265,0645,0734,8244,5474,1442,4541,7371,3291,2741,246957681801551407468407398391380481351281288363365
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,913
3,853
2,851
2,168
619
191
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000001916192,1682,8513,8536,913000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
281
351
412
380
391
464
475
870
1,358
1,309
1,201
503
5,518
0
27,053
0
0
0
0
13,008
13,454
0
0
0
0
0
0
0
868
0
0
0
712
5,695
5,773
5,687
5,435
5,205
5,639
7,608
5,895
5,891
5,694
5,235
482
1,739
1,953
0
0
0
39
39
0
0
0
0
0
0
0
0
0
0
0
0
204
400
14,660
14,265
13,193
12,772
12,341
11,934
11,670
11,270
16,116
15,722
15,343
14,966
17,655
17,276
16,876
16,535
16,063
15,572
32,209
23,443
22,802
22,537
39,684
37,823
26,121
25,325
31,852
29,875
27,860
25,844
23,829
21,813
13,491
12,849
15,009
14,271
12,856
12,856
12,496
11,776
11,416
11,41611,77612,49612,85612,85614,27115,00912,84913,49121,81323,82925,84427,86029,87531,85225,32526,12137,82339,68422,53722,80223,44332,20915,57216,06316,53516,87617,27617,65514,96615,34315,72216,11611,27011,67011,93412,34112,77213,19314,26514,66040020400000000000039390001,9531,7394825,2355,6945,8915,8957,6085,6395,2055,4355,6875,7735,695712000868000000013,45413,008000027,05305,5185031,2011,3091,358870475464391380412351281000
       Long-term Assets Other 
73
145
72
211
70
69
127
130
133
136
602
136
138
7,408
24,335
27,535
36,755
5,588
50,357
53,300
58,892
61,446
48,984
43,020
45,777
41,279
42,036
36,013
34,001
37,732
42,423
31,774
41,301
29,851
28,873
23,820
21,441
29,740
23,628
19,014
17,729
42,331
34,410
32,517
39,900
38,287
34,022
1,786
0
0
0
0
39
0
0
0
0
331
100
381
149
-123
167
-19,372
-17,138
-12,634
-11,703
-11,126
-8,662
-19,684
-17,312
-13,321
-12,858
-12,424
-12,015
-11,753
-14,659
-19,632
-18,952
-18,282
-18,562
-25,714
-26,397
-24,572
-23,082
-21,664
-21,488
-37,510
-28,137
-26,833
-25,835
-41,374
-41,872
-29,828
-28,967
-35,335
-33,221
-31,084
-28,894
-26,683
-24,531
-16,410
1,959
1,792
1,803
1,073
1,073
0
165
259
25916501,0731,0731,8031,7921,959-16,410-24,531-26,683-28,894-31,084-33,221-35,335-28,967-29,828-41,872-41,374-25,835-26,833-28,137-37,510-21,488-21,664-23,082-24,572-26,397-25,714-18,562-18,282-18,952-19,632-14,659-11,753-12,015-12,424-12,858-13,321-17,312-19,684-8,662-11,126-11,703-12,634-17,138-19,372167-12314938110033100003900001,78634,02238,28739,90032,51734,41042,33117,72919,01423,62829,74021,44123,82028,87329,85141,30131,77442,42337,73234,00136,01342,03641,27945,77743,02048,98461,44658,89253,30050,3575,58836,75527,53524,3357,40813813660213613313012769702117214573
> Total Liabilities 
804
871
1,512
1,476
1,476
1,785
1,519
1,497
1,392
1,356
1,271
1,426
1,861
9,544
9,167
16,458
15,863
13,712
18,030
19,429
16,599
9,383
9,461
10,270
9,530
9,451
9,598
8,393
5,259
4,157
2,434
4,208
4,551
3,283
3,092
3,972
4,527
4,162
5,100
5,688
5,737
5,938
9,000
8,609
9,059
11,545
10,318
5,796
25,778
27,018
24,499
24,682
21,794
22,942
18,291
18,631
18,569
20,140
18,966
16,008
16,758
14,612
14,130
6,447
6,286
4,559
4,357
4,390
4,413
7,728
7,852
9,915
10,351
14,479
14,575
12,644
12,830
13,012
11,597
11,492
12,686
16,548
18,119
22,192
21,309
23,884
72,315
76,104
82,366
79,277
78,048
92,721
90,005
96,332
92,978
96,918
94,678
98,361
100,130
101,452
98,510
107,003
113,915
115,831
111,551
98,390
98,390
98,639
93,410
89,389
89,38993,41098,63998,39098,390111,551115,831113,915107,00398,510101,452100,13098,36194,67896,91892,97896,33290,00592,72178,04879,27782,36676,10472,31523,88421,30922,19218,11916,54812,68611,49211,59713,01212,83012,64414,57514,47910,3519,9157,8527,7284,4134,3904,3574,5596,2866,44714,13014,61216,75816,00818,96620,14018,56918,63118,29122,94221,79424,68224,49927,01825,7785,79610,31811,5459,0598,6099,0005,9385,7375,6885,1004,1624,5273,9723,0923,2834,5514,2082,4344,1575,2598,3939,5989,4519,53010,2709,4619,38316,59919,42918,03013,71215,86316,4589,1679,5441,8611,4261,2711,3561,3921,4971,5191,7851,4761,4761,512871804
   > Total Current Liabilities 
804
798
864
843
913
1,167
1,012
1,042
862
949
937
1,087
1,585
2,002
1,587
2,623
2,070
2,084
3,503
4,976
5,089
6,091
4,974
5,854
4,858
4,410
4,630
5,495
5,259
4,157
2,434
4,208
4,551
3,283
3,092
3,972
4,527
4,162
5,100
5,688
5,737
5,938
9,000
8,609
9,059
11,545
10,318
5,796
10,950
11,317
10,436
11,738
10,397
13,171
10,064
11,598
12,139
12,979
12,785
11,114
9,728
9,051
9,654
6,447
6,286
4,559
4,357
4,390
4,413
7,728
7,852
9,915
10,351
14,479
14,575
12,644
12,830
13,012
11,597
11,492
12,686
16,548
18,119
22,192
21,309
23,884
23,554
26,871
29,462
25,716
27,440
37,144
31,525
37,548
33,700
41,919
39,300
42,555
44,070
45,076
41,782
49,923
74,495
114,279
72,949
97,656
97,656
47,294
51,976
52,896
52,89651,97647,29497,65697,65672,949114,27974,49549,92341,78245,07644,07042,55539,30041,91933,70037,54831,52537,14427,44025,71629,46226,87123,55423,88421,30922,19218,11916,54812,68611,49211,59713,01212,83012,64414,57514,47910,3519,9157,8527,7284,4134,3904,3574,5596,2866,4479,6549,0519,72811,11412,78512,97912,13911,59810,06413,17110,39711,73810,43611,31710,9505,79610,31811,5459,0598,6099,0005,9385,7375,6885,1004,1624,5273,9723,0923,2834,5514,2082,4344,1575,2595,4954,6304,4104,8585,8544,9746,0915,0894,9763,5032,0842,0702,6231,5872,0021,5851,0879379498621,0421,0121,167913843864798804
       Short-term Debt 
0
0
0
0
0
69
63
65
66
68
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,314
0
3,728
0
1,866
1,819
1,805
1,762
1,205
1,158
6
3
1
3,327
6
63
18
17
17
17
74
42
42
15
4,676
0
4,617
0
27
43
70
33
70
363
373
412
425
5,208
5,334
5,427
465
476
479
27,113
65,265
27,439
57,555
57,555
7,707
17,894
20,902
20,90217,8947,70757,55557,55527,43965,26527,1134794764655,4275,3345,208425412373363703370432704,61704,67615424274171717186363,3271361,1581,2051,7621,8051,8191,86603,72803,3140000000000000000000000000000000000000000000000000686665636900000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,452
0
0
0
0
0
0
0
0
0
0
0
0
0
26,645
64,789
27,110
27,373
57,143
7,286
12,354
17,455
17,45512,3547,28657,14327,37327,11064,78926,64500000000000003,4520000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
804
798
864
843
913
1,167
949
911
795
814
870
1,087
1,585
2,002
1,587
2,623
2,070
2,084
3,503
4,976
5,089
6,091
4,974
5,854
4,858
4,410
4,630
5,495
5,259
4,157
2,434
4,208
4,551
3,283
3,092
3,972
4,527
4,162
5,100
5,688
5,737
5,938
9,000
8,609
9,059
11,545
10,318
5,796
0
0
0
0
0
0
0
0
0
0
2,800
3,321
2,000
1,147
1,623
1,484
639
731
469
480
3,251
5,446
5,096
1,598
6,816
7,030
7,765
2,360
8,750
9,799
8,019
2,319
8,304
12,872
14,172
5,401
15,609
17,190
20,873
15,583
24,312
20,633
21,780
13,106
24,783
30,606
30,827
17,510
30,603
33,180
35,300
15,526
35,924
43,555
41,076
12,886
34,083
30,457
30,457
6,990
26,277
23,758
23,75826,2776,99030,45730,45734,08312,88641,07643,55535,92415,52635,30033,18030,60317,51030,82730,60624,78313,10621,78020,63324,31215,58320,87317,19015,6095,40114,17212,8728,3042,3198,0199,7998,7502,3607,7657,0306,8161,5985,0965,4463,2514804697316391,4841,6231,1472,0003,3212,80000000000005,79610,31811,5459,0598,6099,0005,9385,7375,6885,1004,1624,5273,9723,0923,2834,5514,2082,4344,1575,2595,4954,6304,4104,8585,8544,9746,0915,0894,9763,5032,0842,0702,6231,5872,0021,5851,0878708147959119491,167913843864798804
       Other Current Liabilities 
0
0
0
0
0
-69
0
65
0
68
67
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,549
5,030
4,182
5,264
3,875
6,677
3,605
4,882
5,139
8,594
8,411
3,649
5,416
3,746
3,719
3,096
3,828
2,023
2,126
2,706
5
2,276
2,753
8,316
208
7,444
6,748
10,266
4,063
3,196
3,561
9,099
4,341
3,634
3,932
16,791
5,700
6,694
2,681
11,261
5,107
5,013
5,627
23,968
6,342
6,541
2,412
23,934
3,439
4,013
3,315
29,031
5,328
5,835
6,252
36,090
11,389
9,606
9,606
32,559
7,768
8,198
8,1987,76832,5599,6069,60611,38936,0906,2525,8355,32829,0313,3154,0133,43923,9342,4126,5416,34223,9685,6275,0135,10711,2612,6816,6945,70016,7913,9323,6344,3419,0993,5613,1964,06310,2666,7487,4442088,3162,7532,27652,7062,1262,0233,8283,0963,7193,7465,4163,6498,4118,5945,1394,8823,6056,6773,8755,2644,1825,0305,549000000000000000000000000000000000000067680650-6900000
   > Long-term Liabilities 
0
73
648
632
562
618
506
456
530
407
335
340
276
7,542
7,580
13,835
13,792
11,628
14,526
14,453
11,510
3,292
4,487
4,416
4,671
5,041
4,967
2,898
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,828
15,701
14,063
12,944
11,398
9,771
8,227
7,034
6,429
7,161
6,181
4,894
7,030
5,561
4,476
7,307
2,305
1,833
1,345
1,569
1,203
11,912
11,793
11,761
12,644
9,372
10,086
9,877
9,869
7,986
7,362
7,927
9,447
6,167
3,486
3,524
3,539
0
48,762
49,233
49,590
49,968
50,349
50,741
51,133
51,553
51,972
52,403
52,834
53,291
53,752
54,227
54,701
55,203
39,420
1,552
38,602
734
734
51,345
41,434
36,493
36,49341,43451,34573473438,6021,55239,42055,20354,70154,22753,75253,29152,83452,40351,97251,55351,13350,74150,34949,96849,59049,23348,76203,5393,5243,4866,1679,4477,9277,3627,9869,8699,87710,0869,37212,64411,76111,79311,9121,2031,5691,3451,8332,3057,3074,4765,5617,0304,8946,1817,1616,4297,0348,2279,77111,39812,94414,06315,70114,828000000000000000000002,8984,9675,0414,6714,4164,4873,29211,51014,45314,52611,62813,79213,8357,5807,542276340335407530456506618562632648730
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
49,233
52,903
53,315
50,349
55,311
58,451
58,755
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000058,75558,45155,31150,34953,31552,90349,233000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,314
3,593
259
4,836
4,618
4,631
4,646
41
62
68
75
94
98
108
100
106
0
46
50
0
0
0
000504601061001089894756862414,6464,6314,6184,8362593,5933,3140000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
341
621
649
647
1,959
1,792
0
1,672
1,073
0
0
0
0001,0731,67201,7921,95964764962134100000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
10,595
9,215
8,207
7,027
6,043
12,083
11,263
10,938
10,341
13,767
17,597
16,910
18,331
31,501
38,805
38,534
37,114
39,555
59,691
56,014
71,673
75,262
70,696
65,586
65,407
65,738
60,690
54,263
62,368
56,971
56,106
53,020
58,562
47,577
45,948
41,959
38,676
52,964
46,295
38,962
78,824
79,427
71,143
65,944
85,366
72,732
57,838
37,319
36,191
38,017
43,608
40,700
37,086
31,893
29,577
51,648
47,869
42,824
38,835
35,196
29,249
26,989
27,276
14,180
15,507
14,081
11,972
9,471
5,862
6,911
2,865
-447
-1,138
-485
7,112
7,441
7,216
7,349
8,016
8,088
17,985
20,784
25,619
21,653
19,805
22,169
22,623
21,862
20,711
17,667
16,028
9,573
5,029
-500
-7,268
-12,817
23,933
19,178
10,369
504
-8,528
-31,255
-18,060
-22,571
-32,311
-41,704
-41,704
-20,870
-23,205
-19,677
-19,677-23,205-20,870-41,704-41,704-32,311-22,571-18,060-31,255-8,52850410,36919,17823,933-12,817-7,268-5005,0299,57316,02817,66720,71121,86222,62322,16919,80521,65325,61920,78417,9858,0888,0167,3497,2167,4417,112-485-1,138-4472,8656,9115,8629,47111,97214,08115,50714,18027,27626,98929,24935,19638,83542,82447,86951,64829,57731,89337,08640,70043,60838,01736,19137,31957,83872,73285,36665,94471,14379,42778,82438,96246,29552,96438,67641,95945,94847,57758,56253,02056,10656,97162,36854,26360,69065,73865,40765,58670,69675,26271,67356,01459,69139,55537,11438,53438,80531,50118,33116,91017,59713,76710,34110,93811,26312,0836,0437,0278,2079,21510,595
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
287,600
289,600
286,800
275,200
283,800
271,900
284,800
282,741
273,139
271,555
266,252
265,194
253,426
258,658
258,701
246,148
224,475
224,687
219,476
218,328
215,045
222,470
222,144
217,076
232,213
238,169
263,069
254,753
256,603
257,741
255,814
286,828
286,905
287,035
287,035
287,035
287,035
287,312
287,312
287,312
333,369
335,011
335,716
335,752
335,752
335,752
335,762
338,751
338,751
338,767
338,767
363,927
363,880
363,927
363,927363,880363,927338,767338,767338,751338,751335,762335,752335,752335,752335,716335,011333,369287,312287,312287,312287,035287,035287,035287,035286,905286,828255,814257,741256,603254,753263,069238,169232,213217,076222,144222,470215,045218,328219,476224,687224,475246,148258,701258,658253,426265,194266,252271,555273,139282,741284,800271,900283,800275,200286,800289,600287,60000000000000000000000000000000000000000000000000000000000
   Retained Earnings -409,062-412,100-408,659-403,851-403,851-393,092-382,649-374,556-367,007-344,280-335,248-325,347-315,833-309,436-300,129-294,580-287,812-282,006-277,462-271,007-269,368-266,194-264,966-233,191-235,572-236,798-233,100-237,450-217,386-214,228-208,988-214,128-215,120-207,829-210,887-212,364-225,172-225,613-246,595-255,837-251,748-247,564-255,723-254,280-257,474-257,632-268,561-264,282-254,005-261,841-244,863-256,560-252,842-246,470-230,614-241,658-239,946-236,090-230,841-218,388-224,783-188,715-184,257-200,311-202,722-194,029-177,250-158,203-147,105-127,507-119,635-117,262-111,139-100,793-93,531-87,214-78,392-69,396-79,922-64,019-58,636-55,442-54,639-40,140-35,864-28,505-23,449-18,537-15,742-14,969-13,040-9,746-30,396-32,258-30,748-22,823-25,762-24,051-22,614-21,411-20,617-19,291-18,164-17,021-17,507-16,231-15,320-14,687-13,786-12,568
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,788
9,019
9,262
9,525
10,783
11,147
11,469
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000011,46911,14710,7839,5259,2629,0198,788000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
23,162
23,001
22,894
22,347
22,274
29,589
28,284
29,102
29,632
32,350
37,001
37,486
40,315
55,261
59,591
69,282
69,372
69,950
69,437
69,054
86,642
91,003
89,233
88,966
93,840
101,524
100,752
107,697
116,513
114,146
118,469
131,041
126,101
124,041
131,049
135,490
139,469
164,103
163,557
158,597
206,063
227,057
230,256
243,527
279,410
275,746
258,403
221,277
224,381
261,619
260,552
270,328
272,048
271,507
270,412
281,707
294,108
295,237
294,759
279,615
290,667
280,551
291,182
-429
-423
-308
-240
-250
-193
-122
-76
-57
-552
-526
-929
-1,141
-1,307
-903
-919
-1,369
-1,168
-1,737
1,028
80
178
-126
-333
95
63
28
-12
-21
-29
4
466
481
-3,872
-3,648
-4,046
-4,427
50
-117
20,109
20,942
21,568
22,794
22,794
23,178
24,211
0
024,21123,17822,79422,79421,56820,94220,109-11750-4,427-4,046-3,648-3,8724814664-29-21-12286395-333-126178801,028-1,737-1,168-1,369-919-903-1,307-1,141-929-526-552-57-76-122-193-250-240-308-423-429291,182280,551290,667279,615294,759295,237294,108281,707270,412271,507272,048270,328260,552261,619224,381221,277258,403275,746279,410243,527230,256227,057206,063158,597163,557164,103139,469135,490131,049124,041126,101131,041118,469114,146116,513107,697100,752101,52493,84088,96689,23391,00386,64269,05469,43769,95069,37269,28259,59155,26140,31537,48637,00132,35029,63229,10228,28429,58922,27422,34722,89423,00123,162



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2023-11-30. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue81,764
Cost of Revenue-19,635
Gross Profit62,12962,129
 
Operating Income (+$)
Gross Profit62,129
Operating Expense-72,756
Operating Income-10,627-10,627
 
Operating Expense (+$)
Research Development30,370
Selling General Administrative15,617
Selling And Marketing Expenses26,769
Operating Expense72,75672,756
 
Net Interest Income (+$)
Interest Income769
Interest Expense-10,361
Other Finance Cost-996
Net Interest Income-10,588
 
Pretax Income (+$)
Operating Income-10,627
Net Interest Income-10,588
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-23,536-8,306
EBIT - interestExpense = -21,201
-23,536
-13,596
Interest Expense10,361
Earnings Before Interest and Taxes (EBIT)-10,840-13,175
Earnings Before Interest and Taxes (EBITDA)-7,539
 
After tax Income (+$)
Income Before Tax-23,536
Tax Provision-421
Net Income From Continuing Ops-23,957-23,957
Net Income-23,957
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses92,391
Total Other Income/Expenses Net-2,32110,588
 

Technical Analysis of Theratech
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Theratech. The general trend of Theratech is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Theratech's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Theratechnologies Inc..

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.521 < 1.64 < 1.67.

The bearish price targets are: 1.42 > 1.42 > 1.36.

Tweet this
Theratechnologies Inc. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Theratechnologies Inc.. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Theratechnologies Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Theratechnologies Inc.. The current macd is -0.00386281.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Theratech price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Theratech. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Theratech price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Theratechnologies Inc. Daily Moving Average Convergence/Divergence (MACD) ChartTheratechnologies Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Theratechnologies Inc.. The current adx is 14.61.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Theratech shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Theratechnologies Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Theratechnologies Inc.. The current sar is 1.15.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Theratechnologies Inc. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Theratechnologies Inc.. The current rsi is 53.04. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
Theratechnologies Inc. Daily Relative Strength Index (RSI) ChartTheratechnologies Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Theratechnologies Inc.. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Theratech price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Theratechnologies Inc. Daily Stochastic Oscillator ChartTheratechnologies Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Theratechnologies Inc.. The current cci is 127.32.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Theratechnologies Inc. Daily Commodity Channel Index (CCI) ChartTheratechnologies Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Theratechnologies Inc.. The current cmo is 10.89.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Theratechnologies Inc. Daily Chande Momentum Oscillator (CMO) ChartTheratechnologies Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Theratechnologies Inc.. The current willr is -59.375.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Theratech is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Theratechnologies Inc. Daily Williams %R ChartTheratechnologies Inc. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Theratechnologies Inc..

Theratechnologies Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Theratechnologies Inc.. The current atr is 0.08264318.

Theratechnologies Inc. Daily Average True Range (ATR) ChartTheratechnologies Inc. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Theratechnologies Inc.. The current obv is 1,791,148.

Theratechnologies Inc. Daily On-Balance Volume (OBV) ChartTheratechnologies Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Theratechnologies Inc.. The current mfi is 67.00.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Theratechnologies Inc. Daily Money Flow Index (MFI) ChartTheratechnologies Inc. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Theratechnologies Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-06-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Theratechnologies Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Theratechnologies Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.042
Ma 20Greater thanMa 501.267
Ma 50Greater thanMa 1001.251
Ma 100Greater thanMa 2001.326
OpenGreater thanClose1.470
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Theratech with someone you think should read this too:
  • Are you bullish or bearish on Theratech? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Theratech? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Theratechnologies Inc.

I send you an email if I find something interesting about Theratechnologies Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Theratechnologies Inc..

Receive notifications about Theratechnologies Inc. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.